Global Drug-Eluting Stents Market Research Report 2024(Status and Outlook)

Global Drug-Eluting Stents Market Research Report 2024(Status and Outlook)



Report Overview:

A drug eluting stent (DES), also known as a drug-eluting stent, carries a drug through a polymer coated on the surface of a metal stent. When the stent is placed in an intravascular lesion, the drug is coated in the polymer coating. The biological effect is exerted by controlled release to the cardiovascular wall tissue by means of elution. The currently marketed drug-eluting stents include a rapamycin-eluting stent and a paclitaxel-eluting stent, both of which prevent in-stent restenosis by inhibiting smooth proliferation of smooth muscle cells.

The Global Drug-Eluting Stents Market Size was estimated at USD 6202.03 million in 2023 and is projected to reach USD 7623.88 million by 2029, exhibiting a CAGR of 3.50% during the forecast period.

This report provides a deep insight into the global Drug-Eluting Stents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug-Eluting Stents Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug-Eluting Stents market in any manner.

Global Drug-Eluting Stents Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Boston Scientific

Medtronic, Inc.

Abbott

Lepu Medical

MicroPort Scientific Corporation

Cook Medical

Terumo

Biosensors International

Balton

AlviMedica Medical Technologies

Biotronik

Shandong JW Medical

Sino Medical

Beijing AMSINO

Liaoning Biomedical Materials R&D Center Co.(LBC)

Market Segmentation (by Type)

Rapamycin

Paclitaxel

Everolimus

Others

Market Segmentation (by Application)

Angina Pectoris

Myocardial Infarction

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Drug-Eluting Stents Market
  • Overview of the regional outlook of the Drug-Eluting Stents Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug-Eluting Stents Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Drug-Eluting Stents
1.2 Key Market Segments
1.2.1 Drug-Eluting Stents Segment by Type
1.2.2 Drug-Eluting Stents Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Drug-Eluting Stents Market Overview
2.1 Global Market Overview
2.1.1 Global Drug-Eluting Stents Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Drug-Eluting Stents Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Drug-Eluting Stents Market Competitive Landscape
3.1 Global Drug-Eluting Stents Sales by Manufacturers (2019-2024)
3.2 Global Drug-Eluting Stents Revenue Market Share by Manufacturers (2019-2024)
3.3 Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Drug-Eluting Stents Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Drug-Eluting Stents Sales Sites, Area Served, Product Type
3.6 Drug-Eluting Stents Market Competitive Situation and Trends
3.6.1 Drug-Eluting Stents Market Concentration Rate
3.6.2 Global 5 and 10 Largest Drug-Eluting Stents Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Drug-Eluting Stents Industry Chain Analysis
4.1 Drug-Eluting Stents Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Drug-Eluting Stents Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Drug-Eluting Stents Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug-Eluting Stents Sales Market Share by Type (2019-2024)
6.3 Global Drug-Eluting Stents Market Size Market Share by Type (2019-2024)
6.4 Global Drug-Eluting Stents Price by Type (2019-2024)
7 Drug-Eluting Stents Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug-Eluting Stents Market Sales by Application (2019-2024)
7.3 Global Drug-Eluting Stents Market Size (M USD) by Application (2019-2024)
7.4 Global Drug-Eluting Stents Sales Growth Rate by Application (2019-2024)
8 Drug-Eluting Stents Market Segmentation by Region
8.1 Global Drug-Eluting Stents Sales by Region
8.1.1 Global Drug-Eluting Stents Sales by Region
8.1.2 Global Drug-Eluting Stents Sales Market Share by Region
8.2 North America
8.2.1 North America Drug-Eluting Stents Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug-Eluting Stents Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug-Eluting Stents Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug-Eluting Stents Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug-Eluting Stents Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Boston Scientific
9.1.1 Boston Scientific Drug-Eluting Stents Basic Information
9.1.2 Boston Scientific Drug-Eluting Stents Product Overview
9.1.3 Boston Scientific Drug-Eluting Stents Product Market Performance
9.1.4 Boston Scientific Business Overview
9.1.5 Boston Scientific Drug-Eluting Stents SWOT Analysis
9.1.6 Boston Scientific Recent Developments
9.2 Medtronic, Inc.
9.2.1 Medtronic, Inc. Drug-Eluting Stents Basic Information
9.2.2 Medtronic, Inc. Drug-Eluting Stents Product Overview
9.2.3 Medtronic, Inc. Drug-Eluting Stents Product Market Performance
9.2.4 Medtronic, Inc. Business Overview
9.2.5 Medtronic, Inc. Drug-Eluting Stents SWOT Analysis
9.2.6 Medtronic, Inc. Recent Developments
9.3 Abbott
9.3.1 Abbott Drug-Eluting Stents Basic Information
9.3.2 Abbott Drug-Eluting Stents Product Overview
9.3.3 Abbott Drug-Eluting Stents Product Market Performance
9.3.4 Abbott Drug-Eluting Stents SWOT Analysis
9.3.5 Abbott Business Overview
9.3.6 Abbott Recent Developments
9.4 Lepu Medical
9.4.1 Lepu Medical Drug-Eluting Stents Basic Information
9.4.2 Lepu Medical Drug-Eluting Stents Product Overview
9.4.3 Lepu Medical Drug-Eluting Stents Product Market Performance
9.4.4 Lepu Medical Business Overview
9.4.5 Lepu Medical Recent Developments
9.5 MicroPort Scientific Corporation
9.5.1 MicroPort Scientific Corporation Drug-Eluting Stents Basic Information
9.5.2 MicroPort Scientific Corporation Drug-Eluting Stents Product Overview
9.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Product Market Performance
9.5.4 MicroPort Scientific Corporation Business Overview
9.5.5 MicroPort Scientific Corporation Recent Developments
9.6 Cook Medical
9.6.1 Cook Medical Drug-Eluting Stents Basic Information
9.6.2 Cook Medical Drug-Eluting Stents Product Overview
9.6.3 Cook Medical Drug-Eluting Stents Product Market Performance
9.6.4 Cook Medical Business Overview
9.6.5 Cook Medical Recent Developments
9.7 Terumo
9.7.1 Terumo Drug-Eluting Stents Basic Information
9.7.2 Terumo Drug-Eluting Stents Product Overview
9.7.3 Terumo Drug-Eluting Stents Product Market Performance
9.7.4 Terumo Business Overview
9.7.5 Terumo Recent Developments
9.8 Biosensors International
9.8.1 Biosensors International Drug-Eluting Stents Basic Information
9.8.2 Biosensors International Drug-Eluting Stents Product Overview
9.8.3 Biosensors International Drug-Eluting Stents Product Market Performance
9.8.4 Biosensors International Business Overview
9.8.5 Biosensors International Recent Developments
9.9 Balton
9.9.1 Balton Drug-Eluting Stents Basic Information
9.9.2 Balton Drug-Eluting Stents Product Overview
9.9.3 Balton Drug-Eluting Stents Product Market Performance
9.9.4 Balton Business Overview
9.9.5 Balton Recent Developments
9.10 AlviMedica Medical Technologies
9.10.1 AlviMedica Medical Technologies Drug-Eluting Stents Basic Information
9.10.2 AlviMedica Medical Technologies Drug-Eluting Stents Product Overview
9.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Product Market Performance
9.10.4 AlviMedica Medical Technologies Business Overview
9.10.5 AlviMedica Medical Technologies Recent Developments
9.11 Biotronik
9.11.1 Biotronik Drug-Eluting Stents Basic Information
9.11.2 Biotronik Drug-Eluting Stents Product Overview
9.11.3 Biotronik Drug-Eluting Stents Product Market Performance
9.11.4 Biotronik Business Overview
9.11.5 Biotronik Recent Developments
9.12 Shandong JW Medical
9.12.1 Shandong JW Medical Drug-Eluting Stents Basic Information
9.12.2 Shandong JW Medical Drug-Eluting Stents Product Overview
9.12.3 Shandong JW Medical Drug-Eluting Stents Product Market Performance
9.12.4 Shandong JW Medical Business Overview
9.12.5 Shandong JW Medical Recent Developments
9.13 Sino Medical
9.13.1 Sino Medical Drug-Eluting Stents Basic Information
9.13.2 Sino Medical Drug-Eluting Stents Product Overview
9.13.3 Sino Medical Drug-Eluting Stents Product Market Performance
9.13.4 Sino Medical Business Overview
9.13.5 Sino Medical Recent Developments
9.14 Beijing AMSINO
9.14.1 Beijing AMSINO Drug-Eluting Stents Basic Information
9.14.2 Beijing AMSINO Drug-Eluting Stents Product Overview
9.14.3 Beijing AMSINO Drug-Eluting Stents Product Market Performance
9.14.4 Beijing AMSINO Business Overview
9.14.5 Beijing AMSINO Recent Developments
9.15 Liaoning Biomedical Materials RandD Center Co.(LBC)
9.15.1 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Basic Information
9.15.2 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Overview
9.15.3 Liaoning Biomedical Materials RandD Center Co.(LBC) Drug-Eluting Stents Product Market Performance
9.15.4 Liaoning Biomedical Materials RandD Center Co.(LBC) Business Overview
9.15.5 Liaoning Biomedical Materials RandD Center Co.(LBC) Recent Developments
10 Drug-Eluting Stents Market Forecast by Region
10.1 Global Drug-Eluting Stents Market Size Forecast
10.2 Global Drug-Eluting Stents Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug-Eluting Stents Market Size Forecast by Country
10.2.3 Asia Pacific Drug-Eluting Stents Market Size Forecast by Region
10.2.4 South America Drug-Eluting Stents Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug-Eluting Stents by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Drug-Eluting Stents Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Drug-Eluting Stents by Type (2025-2030)
11.1.2 Global Drug-Eluting Stents Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Drug-Eluting Stents by Type (2025-2030)
11.2 Global Drug-Eluting Stents Market Forecast by Application (2025-2030)
11.2.1 Global Drug-Eluting Stents Sales (K Units) Forecast by Application
11.2.2 Global Drug-Eluting Stents Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings